Register Login

JAZZ PHARMACEUTICALS PLC (JAZZ)

(10% Negative) JAZZ PHARMACEUTICALS PLC (JAZZ) Announces Delay in care Development Timeline Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Aug. 25, 2026, 8:07 p.m.

    📋 JAZZ PHARMACEUTICALS PLC (JAZZ) - Clinical Trial Update

    Filing Date: 2026-08-25

    Accepted: 2026-08-25 16:06:36

    Event Type: Clinical Trial Update

    Event Details:

    JAZZ PHARMACEUTICALS PLC (JAZZ) Announces Clinical Trial Update JAZZ PHARMACEUTICALS PLC (JAZZ) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: care, approved
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Regulatory Process
    • Collaboration: Tislelizumab plus Chemotherapy
      • targeting HER2 in gastric and gastroesophageal junction cancer. Gastric Cancer. 2015
      • anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with the successful completion of regulatory activities and uncertain regulatory approval, risks related to failure or delays in successfully initiating or completing clinical trials and assessing patients and other risks and uncertainties affecting Jazz Pharmaceuticals and its development programs, including those described from time to time under the caption "Risk Factors" and elsewhere in Jazz Pharmaceuticals' Securities and Exchange Commission filings and reports, including Jazz Pharmaceuticals' Annual Report on Form 10-K for the year ended December 31, 2025

    🔬 Clinical Development Pipeline (JAZZ PHARMACEUTICALS PLC):

    Product Type Development Stage Therapeutic Area Source
    Standard of Care Radiation Therapy Drug Phase PHASE1 Diffuse Midline Glioma (DMG) ClinicalTrials.gov
    Tislelizumab Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    a benzodiazepine drug DRUG Phase PHASE3 Anxiety Disorder ClinicalTrials.gov
    Radiotherapy Drug Phase PHASE3 Diffuse Intrinsic Pontine Glioma ClinicalTrials.gov
    Sativex® and fluconazole concomitantly (Treatment B) Drug Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Fluorouracil Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Zanidatamab Other Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Pertuzumab Other Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Trastuzumab Other Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Carboplatin Other Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Docetaxel Other Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Paclitaxel Other Phase PHASE2 HER2-positive Breast Cancer ClinicalTrials.gov
    Cannabidiol Oral Solution Other Phase PHASE4 Lennox-Gastaut Syndrome ClinicalTrials.gov
    Epidiolex 100 mg/mL Oral Solution Other Phase PHASE2 Sturge - Weber Syndrome (SWS) ClinicalTrials.gov
    Epidiolex Other Preclinical Maternal Complications ClinicalTrials.gov
    Lurbinectedin Other Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Bevacizumab Other Phase PHASE1 Ovarian Cancer ClinicalTrials.gov
    Placebo Other Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Xywav Other Phase PHASE3 Narcolepsy ClinicalTrials.gov
    ONC201 Other Phase PHASE3 Diffuse Intrinsic Pontine Glioma ClinicalTrials.gov
    Everolimus Other Phase PHASE3 Diffuse Intrinsic Pontine Glioma ClinicalTrials.gov
    CBD-OS Other Phase PHASE1 Focal Seizures ClinicalTrials.gov
    Ramucirumab Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Sleep study Other Preclinical Hypersomnia ClinicalTrials.gov
    JZP3507 Other Phase PHASE2 Meningioma ClinicalTrials.gov
    Cannabidiol Other Phase PHASE4 Lennox Gastaut Syndrome ClinicalTrials.gov
    JZP926 capsule Other Phase PHASE2 Juvenile Myoclonic Epilepsy ClinicalTrials.gov
    Zolbetuximab Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Oxaliplatin Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Leucovorin Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Durvalumab Other Phase PHASE2 Extensive-stage Small-cell Lung Cancer ClinicalTrials.gov
    Defibrotide Other Phase PHASE2 Covid19 ClinicalTrials.gov
    5-Fluorouracil Other Phase PHASE3 Gastric Neoplasms ClinicalTrials.gov
    Cisplatin Other Phase PHASE3 Gastric Neoplasms ClinicalTrials.gov
    Capecitabine Other Phase PHASE3 Gastric Neoplasms ClinicalTrials.gov
    CPX-351 Other Phase PHASE2 Acute Myelogenous Leukemia (AML) Due to Therapy ClinicalTrials.gov
    Glasdegib Other Phase PHASE2 Acute Myelogenous Leukemia (AML) Due to Therapy ClinicalTrials.gov
    Vincristine Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Rituximab Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Prednisone Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Positron Emission Tomography Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Pegfilgrastim Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Filgrastim Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Etoposide Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Doxorubicin Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Cyclophosphamide Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Computed Tomography Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Bone Marrow Collection Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Biospecimen Collection Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Asparaginase Erwinia chrysanthemi Other Phase PHASE2 B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative ClinicalTrials.gov
    Evorpacept Other Phase PHASE1 HER2-expressing Cancers ClinicalTrials.gov
    mFOLFOX Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Pembrolizumab Other Phase PHASE2 Gastroesophageal Adenocarcinoma ClinicalTrials.gov
    Quality-of-Life Assessment Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Questionnaire Administration Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Mitoxantrone Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Recombinant Granulocyte Colony-Stimulating Factor Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Cytarabine Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Cladribine Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Liposome-encapsulated Daunorubicin-Cytarabine Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Atezolizumab Other Phase PHASE3 Small-Cell Lung Cancer ClinicalTrials.gov
    DNX-2401 Other Phase PHASE2 Diffuse Intrinsic Pontine Glioma ClinicalTrials.gov
    Paxalisib Other Phase PHASE2 Diffuse Intrinsic Pontine Glioma ClinicalTrials.gov
    Radiation Therapy Drug Phase PHASE2 Diffuse Intrinsic Pontine Glioma ClinicalTrials.gov
    Allogeneic Hematopoietic Stem Cell Transplantation Other Phase PHASE2 Myeloid Neoplasm ClinicalTrials.gov
    MHA Other Phase PHASE2 Myeloid Neoplasm ClinicalTrials.gov
    Osimertinib Other Phase PHASE1 Small Cell Lung Cancer ( SCLC ) ClinicalTrials.gov
    Optional Proton (1H) MR spectroscopy (MRS) Other Phase PHASE1 Diffuse Midline Glioma (DMG) ClinicalTrials.gov
    ONC206 Other Phase PHASE1 Diffuse Midline Glioma (DMG) ClinicalTrials.gov
    ONC206: Dose 2 Other Phase PHASE2 Advanced Pheochromocytoma and Paraganglioma ClinicalTrials.gov
    ONC206: Dose 1 Other Phase PHASE2 Advanced Pheochromocytoma and Paraganglioma ClinicalTrials.gov
    Gemcitabine Other Phase PHASE3 Biliary Tract Cancer ClinicalTrials.gov
    Nabiximols-matched placebo Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Temozolomide Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Nabiximols Other Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Thiotepa Other Phase PHASE2 Acute Myeloid Leukaemia ClinicalTrials.gov
    Busulphan Other Phase PHASE2 Acute Myeloid Leukaemia ClinicalTrials.gov
    Fludarabine Other Phase PHASE2 Acute Myeloid Leukaemia ClinicalTrials.gov
    Vyxeos Other Phase PHASE2 Acute Myeloid Leukaemia ClinicalTrials.gov
    Track 2 Other Approved Daytime Sleepiness ClinicalTrials.gov
    Track 1 Other Approved Daytime Sleepiness ClinicalTrials.gov
    JZP-110 Other Phase PHASE2 Obstructive Sleep Apnea ClinicalTrials.gov
    Best Supportive Care Other Phase PHASE3 Veno-occlusive Disease ClinicalTrials.gov
    GWP42006 Other Phase PHASE1 Epilepsy ClinicalTrials.gov
    Sativex Other Phase PHASE3 Cerebral Palsy ClinicalTrials.gov
    GW-1000-02 Other Phase PHASE3 Multiple Sclerosis ClinicalTrials.gov
    Solriamfetol Other Phase PHASE4 Binge Eating Disorder ClinicalTrials.gov
    Marinol Other Phase PHASE1 Evaluation of Abuse Potential of Sativex ClinicalTrials.gov
    Sativex and omeprazole Other Phase PHASE1 Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 ClinicalTrials.gov
    Sativex and ketoconazole Other Phase PHASE1 Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 ClinicalTrials.gov
    Sativex and rifampicin Other Phase PHASE1 Evaluation of Pharmacokinetics of Sativex in the Absence and Presence of a Known Inducer of CYP3A4 ClinicalTrials.gov
    JZP441 Other Phase PHASE1 Healthy Participants ClinicalTrials.gov
    JZP150 Other Phase PHASE2 Post Traumatic Stress Disorder ClinicalTrials.gov
    Palliative Radiation Therapy Drug Phase PHASE1 Extensive Stage Lung Small Cell Carcinoma ClinicalTrials.gov
    Viread Other Phase PHASE1 Healthy ClinicalTrials.gov
    CMX157 Other Phase PHASE1 Healthy ClinicalTrials.gov
    Custodiol Other Phase PHASE3 Coronary Artery Stenosis ClinicalTrials.gov
    St Thomas Other Phase PHASE3 Coronary Artery Stenosis ClinicalTrials.gov
    CMX001 Other Phase PHASE2 Ebola Virus ClinicalTrials.gov
    mPEG-r-crisantaspase Other Phase PHASE1 Hematologic Malignancies ClinicalTrials.gov
    Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase) Other Phase PHASE2 Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) ClinicalTrials.gov
    Bicarbonate de sodium Other Phase PHASE2 Hematologic Disease ClinicalTrials.gov
    Caphosol Other Phase PHASE2 Hematologic Disease ClinicalTrials.gov
    Brincidofovir Other Preclinical Adenovirus ClinicalTrials.gov
    Ziconotide Other Preclinical Patients With Severe Chronic Pain ClinicalTrials.gov
    pegcrisantaspase Other Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Erwinia Chrysanthemi asparaginase Other Phase PHASE1 Acute Lymphoblastic Leukemia (ALL) ClinicalTrials.gov
    Thioguanine Other Phase PHASE2 Leukemia ClinicalTrials.gov
    Dexamethasone acetate Other Phase PHASE2 Leukemia ClinicalTrials.gov
    Mercaptopurine Other Phase PHASE2 Leukemia ClinicalTrials.gov
    Methotrexate Other Phase PHASE2 Leukemia ClinicalTrials.gov
    Ofatumumab Other Phase PHASE2 Leukemia ClinicalTrials.gov
    PEG asparaginase Other Phase PHASE2 Leukemia ClinicalTrials.gov
    Daunorubicin Other Phase PHASE2 Leukemia ClinicalTrials.gov
    Erwinase Other Phase PHASE2 Hematologic Malignancy ClinicalTrials.gov
    Xyrem Other Phase PHASE3 Narcolepsy With Cataplexy ClinicalTrials.gov
    Placebo oral tablet Other Phase PHASE3 Obstructive Sleep Apnea ClinicalTrials.gov
    External Beam Radiotherapy Drug Phase PHASE2 Metastatic Osteosarcoma ClinicalTrials.gov
    Autologous Stem Cell Infusion Other Phase PHASE2 Metastatic Osteosarcoma ClinicalTrials.gov
    Sm-EDTMP Other Phase PHASE2 Metastatic Osteosarcoma ClinicalTrials.gov
    7+3 (cytarabine and daunorubicin) Other Phase PHASE3 High Risk Acute Myeloid Leukemia ClinicalTrials.gov
    JZP-258 Other Phase PHASE3 Narcolepsy With Cataplexy ClinicalTrials.gov
    Standard of Care Other Phase PHASE2 Adenovirus ClinicalTrials.gov
    CX-8998 Other Phase PHASE2 Parkinson's Disease ClinicalTrials.gov
    ADX-N05 Other Phase PHASE2 Narcolepsy ClinicalTrials.gov
    Valganciclovir Other Phase PHASE3 Cytomegalovirus Disease ClinicalTrials.gov
    Asparaginase Erwinia Chrysanthemi (recombinant) Other Preclinical Acute Lymphoblastic Leukemia ClinicalTrials.gov
    ODSH Other Phase EARLY_PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Placebo Oral Solution Other Phase PHASE3 Idiopathic Hypersomnia ClinicalTrials.gov
    ODSH at 0.250 mg/kg/h Other Phase PHASE1 Protein Losing Enteropathy ClinicalTrials.gov
    ODSH at 0.375 mg/kg/h Other Phase PHASE1 Protein Losing Enteropathy ClinicalTrials.gov
    ODSH at 0.125 mg/kg/h Other Phase PHASE1 Protein Losing Enteropathy ClinicalTrials.gov
    Dociparstat Other Phase PHASE2 Metastatic Pancreatic Cancer ClinicalTrials.gov
    Nab paclitaxel Other Phase PHASE2 Metastatic Pancreatic Cancer ClinicalTrials.gov
    Transition from Xyrem to Xywav Other Preclinical Narcolepsy ClinicalTrials.gov
    GWP42003-P Other Phase PHASE3 Tuberous Sclerosis Complex ClinicalTrials.gov
    Dociparstat sodium Other Phase PHASE2 Coronavirus Disease 2019 (COVID-19) ClinicalTrials.gov
    Control (placebo) Other Phase PHASE2 Opiate Addiction ClinicalTrials.gov
    CBD 800 mg Other Phase PHASE2 Opiate Addiction ClinicalTrials.gov
    CBD 400 mg Other Phase PHASE2 Opiate Addiction ClinicalTrials.gov
    Clobazam Other Phase PHASE2 Epilepsy ClinicalTrials.gov
    GWP42003-P 20 mg/kg/Day Dose Other Phase PHASE2 Epilepsy ClinicalTrials.gov
    Placebo Control Other Phase PHASE3 Epilepsy ClinicalTrials.gov
    GWP42003-P 10 mg/kg/day Dose Other Phase PHASE2 Epilepsy ClinicalTrials.gov
    GWP42003-P 5 mg/kg/day Dose Other Phase PHASE2 Epilepsy ClinicalTrials.gov
    GWP42003 Other Phase PHASE2 Schizophrenia ClinicalTrials.gov
    GWP42004 Other Phase PHASE2 Dyslipidemias ClinicalTrials.gov
    Venetoclax Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Sativex® (Treatment A) Drug Phase PHASE1 Healthy Subjects ClinicalTrials.gov
    Sativex® Other Preclinical Multiple Sclerosis ClinicalTrials.gov
    Haplo-Cord Stem Cell Transplantation Other Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Rabbit Anti-Human T-Lymphocyte Globulin Other Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Melphalan Other Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    GW-2000-02 Other Phase PHASE3 Pain ClinicalTrials.gov
    Gemtuzumab Ozogamicin Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Placebo spray and moxifloxacin Other Phase PHASE1 Effects of Sativex on ECG ClinicalTrials.gov
    Sativex spray and oral moxifloxacin placebo Other Phase PHASE1 Effects of Sativex on ECG ClinicalTrials.gov
    Placebo spray and oral moxifloxacin placebo Other Phase PHASE1 Effects of Sativex on ECG ClinicalTrials.gov
    Placebo (GA-0034) Other Phase PHASE3 Pain ClinicalTrials.gov
    Sodium Oxybate Other Phase PHASE4 REM Sleep Behavior Disorder ClinicalTrials.gov
    Cannabidiol (Epidiolex) Other Phase PHASE4 Study the Efficacy of Epidiolex for Typical Absence Seizures ClinicalTrials.gov
    Idarubicin Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Enasidenib Mesylate Other Phase PHASE2 Recurrent Acute Myeloid Leukemia ClinicalTrials.gov
    Enasidenib Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Midostaurin Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    IV JZP-458 Other Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    IM JZP-458 Other Phase PHASE2 Acute Lymphoblastic Leukemia ClinicalTrials.gov
    Dummy oromucosal Other Phase PHASE2 Pain, Postoperative ClinicalTrials.gov
    Tetrahydrocannabinol Other Phase PHASE2 Pain, Postoperative ClinicalTrials.gov
    Control Other Phase PHASE3 Acute Myeloid Leukemia ClinicalTrials.gov
    JZP341 Other Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Dexamethasone Other Phase PHASE1 Multiple Myeloma ClinicalTrials.gov
    avelumab (PD-L1 inhibitor immunotherapy) + lurbinectedin Drug Phase PHASE2 Metastatic Cancer ClinicalTrials.gov
    CD34+ selected allogeneic stem cell transplant from an HLA-compatible donor Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    Busulfan Other Phase PHASE1 Acute Myeloid Leukemia ClinicalTrials.gov
    JZP541 Other Phase PHASE2 Irritability Associated With Autism Spectrum Disorder ClinicalTrials.gov
    Non-investigational surgery Procedure Phase PHASE1 Locally Advanced Soft Tissue Sarcoma ClinicalTrials.gov
    Tucatinib Other Phase PHASE1 HER2-expressing Cancers ClinicalTrials.gov
    Vinorelbine Other Phase PHASE1 HER2-expressing Cancers ClinicalTrials.gov
    ZW25 (Zanidatamab) Other Phase PHASE1 HER2-expressing Cancers ClinicalTrials.gov
    Dordaviprone (ONC201) Other Phase PHASE2 Endometrial Cancer Recurrent ClinicalTrials.gov
    CBD Oral Solution Other Phase PHASE2 Fragile X Syndrome ClinicalTrials.gov
    CBD Oral Solution (eCBD system Target) Other Phase PHASE2 Fragile X Syndrome ClinicalTrials.gov
    JZP258 (XYWAV) Other Phase PHASE4 Idiopathic Hypersomnia ClinicalTrials.gov
    JZP385 Other Phase PHASE2 Essential Tremor ClinicalTrials.gov
    Fulvestrant Other Phase PHASE2 HER2+/HR+ Breast Cancer ClinicalTrials.gov
    Palbociclib Other Phase PHASE2 HER2+/HR+ Breast Cancer ClinicalTrials.gov
    Lurbinectedin 4 MG Injection [Zepzelca] Other Phase PHASE2 Gastrointestinal Malignancies ClinicalTrials.gov
    ONC201 (dordaviprone) Other Preclinical Glioma ClinicalTrials.gov
    Clofarabine Other Phase PHASE1 Relapsed Pediatric AML ClinicalTrials.gov
    Vyxeos 44 MG / 100 MG Liposome Injection Other Phase PHASE1 Relapsed Pediatric AML ClinicalTrials.gov
    JZP047 Other Phase PHASE1 Healthy Participants ClinicalTrials.gov
    JZP815 Other Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Matched Placebo Other Phase PHASE2 Autism Spectrum Disorder ClinicalTrials.gov
    Cannabidivarin Other Phase PHASE2 Autism Spectrum Disorder ClinicalTrials.gov
    Vyxeos liposomal Other Preclinical Acute Myeloid Leukemia (AML) ClinicalTrials.gov
    Gilteritinib Other Phase PHASE1 Acute Myeloid Leukemia With FLT3/ITD Mutation ClinicalTrials.gov
    JZP898 Other Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Ultrasound Elastography Other Approved Bone Marrow Transplant Complications ClinicalTrials.gov
    Suvecaltamide Other Phase PHASE2 Parkinson Disease ClinicalTrials.gov
    Eribulin Other Phase PHASE3 Metastatic HER2-positive Breast Cancer ClinicalTrials.gov
    Zepzelca Other Preclinical Extensive-stage Small-cell Lung Cancer ClinicalTrials.gov
    CPX-315 Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Cytarabine and Idarubicin Other Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Matching Placebo Other Phase PHASE1 Narcolepsy ClinicalTrials.gov
    Research bone marrow aspirate Other Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Research blood draw Other Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Research skin biopsy Other Phase PHASE1 Myelodysplastic Syndromes ClinicalTrials.gov
    Dordaviprone (ONC201) + Placebo Other Phase PHASE3 H3 K27M ClinicalTrials.gov
    JZP258 Other Phase PHASE4 Narcolepsy ClinicalTrials.gov
    Cannabidiol Oral Solution [Epidiolex] Other Phase PHASE4 Tuberous Sclerosis Complex Associated Neuropsychiatric Disease ClinicalTrials.gov
    Cannabidiol (CBD) DRUG Phase PHASE3 Clinical High Risk for Psychosis (CHR) ClinicalTrials.gov
    Intensive Salvage Therapy DRUG Phase PHASE2 Acute Myeloid Leukemia ClinicalTrials.gov
    Sodium Oxybate Oral Solution (6 grams) DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    Sodium Oxybate & 8 Tablets DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    Sodium Oxybate & 6 Tablets DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    THC Alone DRUG Phase PHASE3 Palliative Care ClinicalTrials.gov
    tetracaine gel DRUG Phase PHASE4 Healthy ClinicalTrials.gov
    Rapydan DRUG Phase PHASE4 Healthy ClinicalTrials.gov
    Clonazepam DRUG Phase PHASE2 Epilepsy ClinicalTrials.gov
    Erwinia L-asparaginase DRUG Preclinical Leukemia, Acute Lymphoblastic ClinicalTrials.gov
    Xyrem® DRUG Phase PHASE3 Fibromyalgia ClinicalTrials.gov
    CPX-351 (Cytarabine:Daunorubicin) Liposome Injection DRUG Phase PHASE1 Hematologic Neoplasms ClinicalTrials.gov
    CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injection DRUG Phase PHASE2 Colorectal Neoplasms ClinicalTrials.gov
    Xyrem (sodium oxybate) oral solution DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov
    experimental anti-anxiety drug DRUG Phase PHASE3 Anxiety Disorder ClinicalTrials.gov
    Placebo (P) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Modafinil (M) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Zolpidem (Z) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Xyrem (X) DRUG Phase PHASE4 Obstructive Sleep Apnea Syndrome ClinicalTrials.gov
    Modafinil (Placebo) DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Modafinil at established dose DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov
    Xyrem Placebo DRUG Phase PHASE3 Narcolepsy ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: JAZZ PHARMACEUTICALS PLC
    • Ticker Symbol: JAZZ

Search

News categories